Skip to main content
Erschienen in: Medical Oncology 4/2015

01.04.2015 | Original Paper

Methods of reconstruction after esophagectomy on long-term health-related quality of life: a prospective, randomized study of 5-year follow-up

verfasst von: Min Zhang, Qiang Li, Hong-Tao Tie, Ying-Jiu Jiang, Qing-Chen Wu

Erschienen in: Medical Oncology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

The health-related quality of life (HRQL) is generally accepted as an important parameter for patients undergoing oncologic surgery. We conducted this prospective, randomized study to compare the effect of narrow gastric tube (NGT) reconstruction and whole-stomach (WS) reconstruction on the long-term HRQL in patients after esophagectomy. One hundred and four patients undergoing esophagectomy were enrolled in our study from 2007 to 2008, with 52 in NGT group and 52 in WS group. A questionnaire with reference to the European Organization for Research and Treatment of Cancer QLQ-C30 and QLQ-OES18 was used to assess the HRQL at 3 weeks, 6 months, 1, 2, 3, 4, and 5 years after esophagectomy. Data collection and follow-up were performed regularly. No significant difference was found between NGT group and WS group in the patients’ baseline characteristics. Patients in NGT group had decreased risk of postoperative reflux esophagitis by comparison with those in WS group. The 5-year cumulative survival rate was 42 % (NGT) and 27 % (WS), respectively. Compared with WS group, a significant increased survival rate (P = 0.027) was found in NGT group. Additionally, patients had lower dysphagia scores (better) in NGT group than those in WS group at 5 years after esophagectomy (P < 0.05). However, the scores of the other scales did not show statistical difference at 5-year follow-up. NGT is a better option for the reconstruction after esophagectomy because of decreased risk of postoperative complication, increased survival rate, and better HRQL, and NGT should be preferred to be recommended for patients undergoing esophagectomy.
Literatur
1.
Zurück zum Zitat Rice T, Rush V, Apperson Hansen C, et al. Worldwide esophageal cancer collaboration. Dis Esophagus. 2009;22(1):1–8.CrossRefPubMed Rice T, Rush V, Apperson Hansen C, et al. Worldwide esophageal cancer collaboration. Dis Esophagus. 2009;22(1):1–8.CrossRefPubMed
2.
Zurück zum Zitat McLarty AJ, Deschamps C, Trastek VF, et al. Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann Thorac Surg. 1997;63(6):1568–72.CrossRefPubMed McLarty AJ, Deschamps C, Trastek VF, et al. Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann Thorac Surg. 1997;63(6):1568–72.CrossRefPubMed
3.
Zurück zum Zitat Schmidt CE, Bestmann B, Kuchler T, et al. Quality of life associated with surgery for esophageal cancer: differences between collar and intrathoracic anastomoses. World J Surg. 2004;28(4):355–60.CrossRefPubMed Schmidt CE, Bestmann B, Kuchler T, et al. Quality of life associated with surgery for esophageal cancer: differences between collar and intrathoracic anastomoses. World J Surg. 2004;28(4):355–60.CrossRefPubMed
4.
Zurück zum Zitat Blazeby JM, Farndon JR, Donovan J, Alderson D. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer. 2000;88(8):1781–7.CrossRefPubMed Blazeby JM, Farndon JR, Donovan J, Alderson D. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer. 2000;88(8):1781–7.CrossRefPubMed
5.
Zurück zum Zitat Brooks JA, Kesler KA, Johnson CS, et al. Prospective analysis of quality of life after surgical resection for esophageal cancer: preliminary results. J Surg Oncol. 2002;81(4):185–94.CrossRefPubMed Brooks JA, Kesler KA, Johnson CS, et al. Prospective analysis of quality of life after surgical resection for esophageal cancer: preliminary results. J Surg Oncol. 2002;81(4):185–94.CrossRefPubMed
6.
Zurück zum Zitat Lauschke H, Tolba R, Hirner A. History of surgical esophageal replacement. Chirurg. 2001;72(8):973–7.CrossRefPubMed Lauschke H, Tolba R, Hirner A. History of surgical esophageal replacement. Chirurg. 2001;72(8):973–7.CrossRefPubMed
7.
Zurück zum Zitat Judith B, Daan PL, Sjoerd GE, et al. International servery on esophageal cancer: part I surgical techniques. Dis Esophagus. 2009;22:195–202.CrossRef Judith B, Daan PL, Sjoerd GE, et al. International servery on esophageal cancer: part I surgical techniques. Dis Esophagus. 2009;22:195–202.CrossRef
9.
Zurück zum Zitat Yamamoto S, Makuuchi H, Shimada H, et al. Clinical analysis of reflux esophagitis following esophagectomy with gastric tube reconstruction. J Gastroenterol. 2007;42(5):342–5.CrossRefPubMed Yamamoto S, Makuuchi H, Shimada H, et al. Clinical analysis of reflux esophagitis following esophagectomy with gastric tube reconstruction. J Gastroenterol. 2007;42(5):342–5.CrossRefPubMed
10.
Zurück zum Zitat Zhang C, Wu QC, Hou PY, et al. Impact of the method of reconstruction after oncologic oesophagectomy on quality of life–a prospective, randomised study. Eur J Cardiothorac Surg. 2011;39:109–14.CrossRefPubMed Zhang C, Wu QC, Hou PY, et al. Impact of the method of reconstruction after oncologic oesophagectomy on quality of life–a prospective, randomised study. Eur J Cardiothorac Surg. 2011;39:109–14.CrossRefPubMed
11.
Zurück zum Zitat Collard JM, Otte JB, Reynaert M, Kestens PJ. Quality of life three years or more after esophagectomy for cancer. J Thorac Cardiovasc Surg. 1992;104:391–4.PubMed Collard JM, Otte JB, Reynaert M, Kestens PJ. Quality of life three years or more after esophagectomy for cancer. J Thorac Cardiovasc Surg. 1992;104:391–4.PubMed
12.
Zurück zum Zitat Koichiro S, Satoshi I, Masafumi S, et al. Chest pain and ST segment depression caused by expansion of gastric tube used for esophageal reconstruction. Intern Med. 2005;44(3):217–21.CrossRef Koichiro S, Satoshi I, Masafumi S, et al. Chest pain and ST segment depression caused by expansion of gastric tube used for esophageal reconstruction. Intern Med. 2005;44(3):217–21.CrossRef
13.
Zurück zum Zitat Tetsuya T, Terunal A, Takao S, et al. Marked reversible ST-T abnormalities induced by cardiac compression from a retrosternal gastric tube used to reconstruct the esophagus after tumor resection. Int Heart J. 2006;47(3):475–82.CrossRef Tetsuya T, Terunal A, Takao S, et al. Marked reversible ST-T abnormalities induced by cardiac compression from a retrosternal gastric tube used to reconstruct the esophagus after tumor resection. Int Heart J. 2006;47(3):475–82.CrossRef
14.
Zurück zum Zitat Walther B, Johansson J, Johnsson F, et al. Cervical or thoracic anastomosis after esophageal resection and gastric tube reconstruction: a prospective randomized trial comparing sutured neck anastomosis with stapled intrathoracic anastomosis. Ann Surg. 2003;238(6):803–12.CrossRefPubMedCentralPubMed Walther B, Johansson J, Johnsson F, et al. Cervical or thoracic anastomosis after esophageal resection and gastric tube reconstruction: a prospective randomized trial comparing sutured neck anastomosis with stapled intrathoracic anastomosis. Ann Surg. 2003;238(6):803–12.CrossRefPubMedCentralPubMed
15.
Zurück zum Zitat Bonavina L, Anselmino M, Ruol A, et al. Functional evaluation of the intrathoracic stomach as an oesophageal substitute. Br J Surg. 1992;79:529–32.CrossRefPubMed Bonavina L, Anselmino M, Ruol A, et al. Functional evaluation of the intrathoracic stomach as an oesophageal substitute. Br J Surg. 1992;79:529–32.CrossRefPubMed
16.
Zurück zum Zitat Domergue J, Veyrac M, Huin-Yan S, et al. pH monitoring for 24 hours of gastroesophageal reflux and gastric function after intrathoracic gastroplasty after esophagectomy. Surg Gynecol Obstet. 1990;171:107–10.PubMed Domergue J, Veyrac M, Huin-Yan S, et al. pH monitoring for 24 hours of gastroesophageal reflux and gastric function after intrathoracic gastroplasty after esophagectomy. Surg Gynecol Obstet. 1990;171:107–10.PubMed
17.
Zurück zum Zitat Gutschow C, Collard JM, Romagnoli R, Salizzoni M, Holscher A. Denervated stomach as an esophageal substitute recovers intraluminal acidity with time. Ann Surg. 2001;233:509–14.CrossRefPubMedCentralPubMed Gutschow C, Collard JM, Romagnoli R, Salizzoni M, Holscher A. Denervated stomach as an esophageal substitute recovers intraluminal acidity with time. Ann Surg. 2001;233:509–14.CrossRefPubMedCentralPubMed
18.
Zurück zum Zitat Poghosyan T, Gaujoux S, Chirica M, et al. Functional disorders and quality of life after esophagectomy and gastric tube reconstruction for cancer. J Visc Surg. 2011;148(5):e327–35.CrossRefPubMed Poghosyan T, Gaujoux S, Chirica M, et al. Functional disorders and quality of life after esophagectomy and gastric tube reconstruction for cancer. J Visc Surg. 2011;148(5):e327–35.CrossRefPubMed
19.
Zurück zum Zitat Zhang M, Wu QC, Li Q, et al. Comparison of the health-related quality of life in patients with narrow gastric tube and whole stomach reconstruction after oncologic esophagectomy: a prospective randomized study. Scand J Surg. 2013;102(2):77–82.CrossRefPubMed Zhang M, Wu QC, Li Q, et al. Comparison of the health-related quality of life in patients with narrow gastric tube and whole stomach reconstruction after oncologic esophagectomy: a prospective randomized study. Scand J Surg. 2013;102(2):77–82.CrossRefPubMed
20.
Zurück zum Zitat Takeuchi H, Kawakubo H, Saikawa Y, Omori T, Kitagawa Y. Clinical significance of micrometastases in patients with esophageal cancer. Nihon Geka Gakkai Zasshi. 2013;114(1):9–12.PubMed Takeuchi H, Kawakubo H, Saikawa Y, Omori T, Kitagawa Y. Clinical significance of micrometastases in patients with esophageal cancer. Nihon Geka Gakkai Zasshi. 2013;114(1):9–12.PubMed
21.
Zurück zum Zitat Egberts JH, Schniewind B, Bestmann B, et al. Impact of the site of anastomosis after oncologic esophagectomy on quality of life: a prospective, longitudinal outcome study. Ann Surg Oncol. 2008;15(2):566–75.CrossRefPubMed Egberts JH, Schniewind B, Bestmann B, et al. Impact of the site of anastomosis after oncologic esophagectomy on quality of life: a prospective, longitudinal outcome study. Ann Surg Oncol. 2008;15(2):566–75.CrossRefPubMed
22.
Zurück zum Zitat van Heijl M, Gooszen JA, Fockens P, et al. Risk factors for development of benign cervical strictures after esophagectomy. Ann Surg. 2010;251:1064–9.CrossRefPubMed van Heijl M, Gooszen JA, Fockens P, et al. Risk factors for development of benign cervical strictures after esophagectomy. Ann Surg. 2010;251:1064–9.CrossRefPubMed
23.
Zurück zum Zitat Sutcliffe RP, Forshaw MJ, Tandon R, et al. Anastomotic strictures and delayed gastric emptying after esophagectomy: incidence, risk factors and management. Dis Esophagus. 2008;21:712–7.CrossRefPubMed Sutcliffe RP, Forshaw MJ, Tandon R, et al. Anastomotic strictures and delayed gastric emptying after esophagectomy: incidence, risk factors and management. Dis Esophagus. 2008;21:712–7.CrossRefPubMed
24.
Zurück zum Zitat Blazeby JM, Conroy T, Hammerlid E, et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer. 2003;39(10):1384–94.CrossRefPubMed Blazeby JM, Conroy T, Hammerlid E, et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer. 2003;39(10):1384–94.CrossRefPubMed
Metadaten
Titel
Methods of reconstruction after esophagectomy on long-term health-related quality of life: a prospective, randomized study of 5-year follow-up
verfasst von
Min Zhang
Qiang Li
Hong-Tao Tie
Ying-Jiu Jiang
Qing-Chen Wu
Publikationsdatum
01.04.2015
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 4/2015
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-015-0568-0

Weitere Artikel der Ausgabe 4/2015

Medical Oncology 4/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.